Lund University logotype, link to Lund University

Listen
Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Emma Ahlqvist

Emma Ahlqvist

Assistant researcher

Emma Ahlqvist
Contact details
Organisation
Webpage
Other affiliations

Research interest

Our research is focused on personalized medicine in diabetes and the genetics of diabetes related traits.

Diabetes is presently classified into two main forms, type 1 (T1D) and type 2 diabetes (T2D), but both diseases are highly heterogeneous with respect to disease progression, response to medication and risk of developing complications. One of the main goals of the group is to subclassify diabetes into more homogeneous subgroups. Such an improved classification could help tailor and target early treatment to patients who would benefit most, thereby representing a first step towards precision medicine in diabetes.

Genomics provide invaluable tools to elucidate disease mechanisms in an unbiased manner and to identify causal relationships between biomarkers and disease outcomes. We use genome-wide association studies and next-generation sequencing to identify genetic variation that affects risk of diabetes and diabetic complications, as well as related traits, such as hormone secretion and biomarker concentrations. Recently, we have focused on the genetics of incretin hormone secretion and on the role of incretins in human physiology and diabetic complications.

Publications

Displaying of publications. Sorted by year, then title.

28 Feb 2018